TB Research

Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint

Monica Sharma, Kamini Walia, N.K. Bansal

Drug Target Insights · 2022-12

Abstract

Drug-resistant infections are a serious threat globally which demands cost-effective solutions to meet the unmet needs in their diagnosis and treatment. Gram-negative pathogens, drug-resistant tuberculosis, and multidrugresistant Salmonella typhi have been reported as cause of resistant infections in developing countries. Here, we discuss the priority pathogens and conditions for which feasible solutions adaptable to low-resource settings are required to address the antimicrobial resistance in pathogens. These solutions will be helpful in containing the spread of antimicrobial resistance and better patient outcomes.

MeSH terms

  • Medicine
  • Intensive care medicine
  • Drug resistance
  • Tuberculosis
  • Salmonella typhi
  • Antimicrobial
  • Antibiotic resistance
  • Drug resistant tuberculosis
  • Developing country
  • Extensively drug-resistant tuberculosis
  • Limited resources
  • Multi-drug-resistant tuberculosis
  • Drug
  • Antibiotics